Myelodysplastic and myeloproliferative disorders of childhood: A study of 167 patients

Blood

Volumn 93, Issue 2, 1999, Pages 459-466

  Luna Fineman, Sandra ^a   Shannon, Kevin M ^b   Atwater, Susan K ^b   Davis, Jeffrey ^b   Masterson, Margaret ^b   Ortega, Jorge ^b   Sanders, Jean ^b   Steinherz, Peter ^b   Weinberg, Vivian ^b   Lange, Beverly J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CHILDHOOD DISEASE; CLINICAL FEATURE; COMORBIDITY; DOWN SYNDROME; FEMALE; HEPATOSPLENOMEGALY; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0033555976     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.2.459.402k19_459_466     Document Type: Article

References (52)

1. Lichtmann M: Classification and clinical manifestations of the hematopoietic stem cell disorders, in Williams W, Beutler E, Erslev A, Lichtmann M (eds): Hematology. New York, NY, McGraw-Hill, 1990, p 148
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189, 1982
3. Brandwein JM, Horsman D, Eaves A, Eaves CJ, Massing BG, Wadsworth LD, Rogers PCJ, Kalousek D: Childhood myelodysplasia: Suggested classification as myelodysplastic syndromes. Am J Pediatr Hematol Oncol 12:63, 1990
4. Niemeyer C, Stollmann-Gibbels B, Ebell W, Gaedicke G, Creutzig U: Myelodysplastische erkrankungen im Kindesalter. Kin Padiatr 204:190, 1992
5. Niemeyer C, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van't Veer-Korhof E, van Wering E, Zimmermann M: Chronic myelomonocytic leukemia in childhood: A retrospective analysis of 110 cases. Blood 89:3534, 1997
6. Wegelius R: Bone marrow dysfunctions preceding acute leukemia in children: A clinical study. Leuk Res 16:71, 1992
7. Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C, Cox C: The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals by the French-American-British Cooperative Leukaemia Group. Br J Haematol 87:746, 1994
8. Greenberg P, Cox C, LeBeau M, Fenaux P, Morel M, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J: International scoring system for evaluating prognosis in myelodysplastic syndromes. J Clin Oncol 89:2079, 1997
9. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS: Selective hypersensitivity to granulocyte-macrophage colony stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 77:925, 1991
10. Hasle H, Jacobsen BB, Pedersen NT: Myelodysplastic syndromes in childhood: A population based study of nine cases. Br J Haematol 81:495, 1992
11. Bader-Meunier B, Tchernia G, Mielot F, Fontaine J, Thomas C, Lyonnet S, Lavergne JM, Dommergues JP: Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 130:885, 1997
12. Castro-Malaspina H, Schaison G, Passe S, Pasquier A, Berger R, Bayle-Weisgerber C, Miller D, Seligmann M, Bernard J: Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Cancer 54:675, 1984
13. Luna-Fineman S, Shannon K, Lange B: Childhood monosomy 7: Epidemiology, biology and mechanistic implications. Blood 85:1985, 1995
14. Passmore S, Hann C, Stiller P, Ramani G, Swansbury B, Gibbons B, Reeves B, Chessells J: Pediatric myelodysplasia: A study of 68 children and a new prognostic scoring system. Blood 85:1742, 1995
15. Emanuel P, Shannon K, Castelberry R: Juvenile myelomonocytic leukemia: molecular understanding and prospects of therapy. Mol Med Today 2:468, 1996
16. Arico M, Biondi A, Pui C: Juvenile myelomonocytic leukemia. Blood 90:479, 1997
17. Niemeyer C, Fenu S, Hasle H, Mann G, Stary J, van Wering E: Response: Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood 91:365, 1998
18. Tricot G, De Wolf-Peeters C, Vlietinck P, Werwilghen R: Bone marrow histology in myelodysplastic syndromes. II Prognostic value of abnormal localization of immature precursors in MDS. Br J Haematol 58:217, 1984
19. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
20. Peto R, Pike M, Armitage P, Breslow N, Cox D, Howard S, Mantel N, McPherson K, Peto J, Smith P: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1, 1977
21. Bleyer W, Tejeda H, Murphy S, Brawley O, Smith M, Ungerleider R: Equal participation of minority patients in U.S. national pediatric cancer clinical trials. J Pediatr Hematol Oncol 19:423, 1997
22. Barnard D, Kalousek DK, Wiersma SR, Lange BJ, Benjamin DR, Arthur DC, Burckley JD, Kobrinsky N, Neudorf S, Sanders J, Miller LP, DeSwarte J, Shina DC, Hammond GD, Woods WG: Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: A report from the Children's Cancer Group. Leukemia 10:5, 1996
23. Wessels J, Febbe W, van der Keur D, Landegent J, van der Plas D, den Ottolander G, Roozendaal K, Beverstock G: t(5;12)(q31;p12) A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genet Cytogenet 65:7, 1993
24. Shannon KM, O'Connell P, Martin GA, Paderanga D, Olson K, Dinndorf P, McCormick F: Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994
25. Golub TR, Barker GF, Lovett M, Gilliland DG: Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77:307, 1994
26. Pellier I, LeMoine P, Rialland X, Francois S, Baranger L, Blanchet O, Larget-Piet L, Ifrah N: Myelodysplastic syndrome with t(5;12)(q31;p12-p13) and eosinophilia: A pediatric case with review of the literature. J Pediatric Hematol Oncol 18:285, 1996
27. Bollag G, Clapp D, Shih S, Adler F, Zhang Y, Thompson P, Lange B, Freedman M, McCormick F, Jacks T: Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells. Nat Genet 12:144, 1996
28. ras. Blood 84:3435, 1994
29. Miyauchi J, Asada M, Sasaki M, Tsunematsu Y, Kojima S, Mizutani S: Mutations of the N-ras gene in juvenile chronic myelogenous leukemia. Blood 83:2248, 1994
30. Side L, Taylor B, Cayouett M, Conner E, Thompson P, Luce M, Shannon K: Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders. N Engl J Med 336:1713, 1997
31. Bader-Meunier B, Mielot F, Tchernia G, Buisine J, Delsol G, Duchayne E, Lemerle S, Leverger G, de Lumley L, Manel AM: Myelodysplastic syndromes in childhood: Report of 49 patients from a French multicenter study. French Society of Paediatric Haematology and Immunology. Br J Haematol 92:344, 1996
32. Side L, Emanuel P, Taylor B, Franklin J, Thompson P, Castleberry R, Shannon K: Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1. Blood 92:267, 1998
33. Lange B, Kobrinsky N, Barnard D, Arthur D, Buckley J, Howells W, Gold S, Sanders J, Neudorf S, Smith F, Woods W: Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891. Blood 91:608, 1998
34. Auerbach A, Allen R: Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 51:1, 1991
35. Dong F, Hoefsloot L, Schelen A, Broeders C, Meijer Y, Veerman A, Touw I, Lowenberg B: Identification of a nonsense mutation in the granulocyte-colony stimulating factor receptor in severe congenital neutropenia. Proc Natl Acad Sci USA 91:4480, 1994
36. Guba S, Sartor C, Hutchinson R, Boxer L, Emerson S: Granulocyte colony-stimulating factor (G-CSF) production and G-CSF receptor structure in patients with congenital neutropenia. Blood 83:1486, 1994
37. Kalra R, Dale D, Freedman M, Bonilla M, Weinblatt M, Ganser A, Bowman P, Abish S, Priest J, Oseas R, Shannon K: Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 86:4579, 1995
38. Morel P, Hebbar M, Lai JL, Duhamel A, Preudomme C, Wattel E, Bauters F, Fenaux P: Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases. Leukemia 7:1315, 1993
39. Shannon KM, Watterson J, Johnson P, O'Connell P, Lange B, Shah N, Steinherz P, Kan YW, Priest JR: Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: Epidemiology and molecular analysis. Blood 79:1311, 1992
40. Carroll WL, Morgan R, Glader BE: Childhood bone marrow monosomy 7 syndrome: A familial disorder? J Pediatr 107:578, 1985
41. Shannon KM, Turhan AG, Rogers PC, Kan YW: Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7. Genomics 14:121, 1992
42. Imashuku S, Tsuchida M, Sasaki M, Shimokawa T, Nakamura H, Matsuyama T, Taniguchi N, Oda M, Higuchi S, Ishimoto K: Recombinant human granulocyte-colony stimulating factor in the treatment of patients with chronic benign granulocytopenia and congenital agranulocytosis (Kostmann's syndrome). Acta Paediatr 81:133, 1992
43. Fischer K, Fröhling S, Scherer S, McAllisterBrown J, Scholl C, Stilgenbauer S, Tsui L, Lichter P, Döhner H: Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89:2036, 1997
44. Kere J, Ruutu T, Lahtinen R, de la Chapelle A: Molecular characterization of chromosome 7 long arm deletions in myeloid disorders. Blood 70:1349, 1987
45. Kere J, Ruutu T, Davies KA, Roninson IB, Watkins PC, Winqvist R, de la Chapelle A: Chromosome 7 long arm deletion in myeloid disorders: A narrow breakpoint region in 7q22 defined by molecular mapping. Blood 73:230, 1989
46. LeBeau M, Espinosa R, Davis E, Eisenbart J, Larson R, Green E: Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88:1930, 1996
47. Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Brock Jacobsen B: Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 10:1269, 1996
48. Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M: Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy. Blood 90:2969, 1997
49. Woods WG, Nesbit ME, Buckley J, Lampkin BC, McCreadie S, Kim TH, Piomelli S, Kersey JH, Feig S, Bernstein I, Hammond D: Correlation of chromosome abnormalities with patient characteristics, histologic subtype, and induction success in children with acute nonlymphocytic leukemia. J Clin Oncol 3:3, 1985
50. Locatelli F, Zecca M, Niemeyer C, Angelucci E, Arcese G, Bender-Gotze C, Bonetti F, Burdach S, Dini G, Ebell W, Friedrich W, Hasle H, Hermann J, Jacobsen N, Klingebiel T: Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. Bone Marrow Transplant 18:63, 1996
51. Locatelli F, Niemeyer C, Angelucci E, Bender-Gotze C, Burdach S, Ebell W, Friedrich W, Hasle H, Herman J, Jacobsen N: Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: A report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 15:566, 1997
52. Sanders JE, Buckner CD, Thomas ED, Fleischer R, Sullivan KM, Appelbaum FA, Storb R: Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood 71:1144, 1988